Page last updated: 2024-09-04

aclacinomycin and HIV Coinfection

aclacinomycin has been researched along with HIV Coinfection in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Duverger, A; Jones, J; Kappes, J; Kutsch, O; Shishido, T; Wagner, F; Wolschendorf, F1

Other Studies

1 other study(ies) available for aclacinomycin and HIV Coinfection

ArticleYear
Selected drugs with reported secondary cell-differentiating capacity prime latent HIV-1 infection for reactivation.
    Journal of virology, 2012, Volume: 86, Issue:17

    Topics: Aclarubicin; Anti-HIV Agents; Cell Differentiation; Cell Line; Dactinomycin; Drug Evaluation, Preclinical; HIV Infections; HIV-1; Humans; T-Lymphocytes; Virus Activation; Virus Latency

2012